Nicole Pratt

BioRelated/Noteworthy Publications
Nicole Pratt

Nicole Pratt, PhD
Associate Professor
University of South Australia

Nicole is a biostatistician and Deputy Director the Quality Use of Medicines and Pharmacy Research Centre, University of South Australia and a chief investigator on the Centre of Research Excellence on Post-market Surveillance of Medicines and Medical Devices. Nicole is responsible for evaluating the quality use of medicines program: Veterans’ Medicines Advice and Therapeutics Education Service (Veterans’ MATES). Veterans’ MATES uses administrative claims data to develop and evaluate interventions to improve use of medicines in the veteran community in Australia. Nicole is also a member of the Drug Utilisation Sub-Committee (DUSC) of the Australian Government Department of Health Pharmaceutical Benefits Advisory Committee. She is a collaborator of the Asian Pharmacoepidemiology Network (AsPEN) (

Pratt, NL, Illomaki J, Raymond C, Roughead EE. The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study. BMC Med Res Methodol 2014 14:66 DOI: 10.1186/1471-2288-14-66

Pratt NL, Ramsay EN, Kalish-Ellett LM, Nguyen TA, Barratt JD, Roughead EE, Association Between Use of Multiple Psychoactive Medicines and Hospitalization for Falls: Retrospective Analysis of a Large Healthcare Claim Database. Drug Safety 2014 (Published online)

Wahab IA, Pratt NL, Wiese MD, Kalisch LM, Roughead EE. Sequence symmetry analysis and disproportionality analyses: What percentage of adverse drug reaction do they signal? Advances in Pharmacoepidemiology and Drug Safety 2014 (In-press)

Wahab IA, Pratt NL, Kalisch LM, Roughead EE. Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database: a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia. Drug Safety 2014. Jan;37(1):53-64

AsPEN Investigators, The Asian Pharmacoepidemiology Network (AsPEN): Promoting multi-national collaboration for pharmaco-epidemiologic research in Asia. Pharmacoepidemiology and Drug Safety, 2013. 22:p 700-4

Pratt NL, AsPEN Investigators, Multi-country rapid adverse drug event assessment: The Asian Pharmacoepidemiology Network antipsychotic and acute hyperglycaemia study, Pharmacoepidemiology and Drug Safety, 2013. 22:p 915-24

Wahab I, Pratt NL, Kalish LM, Roughead E.E. The Validity of Sequence Symmetry Analysis (SSA) for adverse drug event detection. Pharmacepidemiol Drug Saf, 2013. 22(5): p. 496-502

Pratt NL, Roughead EE, Salter A, Ryan P, Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review. BMC Medical Research Methodology, 2012, 12:72

Pratt NL, Roughead EE, Ramsay E, Salter A, Ryan P, Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly: a self-controlled case-series analysis in an Australian health care claims database. Drug Safety, 2011;34(7):567-75

Pratt NL, Roughead E.E, Ramsay E, Salter A, Ryan P, Risk of hospitalization for stroke associated with antipsychotic use in the elderly: a self controlled case-series. Drugs & Aging, 2010 Nov 1;27(11):885-93

Pratt NL, Roughead E.E, Ryan P, Salter A. Antipsychotics and the risk of death in the elderly: An instrumental variable analysis using two preference based instruments. Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):699-707

Pratt NL, Roughead E.E, Ryan, P, Gilbert A.L, Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations. Drugs Aging. 2010;27(1):63-71